|
Sep 26
|
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
|
|
Aug 29
|
AbCellera to Present at Upcoming Investor Conferences in September
|
|
Aug 29
|
AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024
|
|
Jun 25
|
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jun 13
|
Down 57%, Is AbCellera Biologics a Buy on the Dip?
|
|
Jun 6
|
We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate
|
|
May 28
|
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
|
|
May 10
|
Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71
|
|
May 8
|
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Q1 2024 Abcellera Biologics Inc Earnings Call
|
|
May 8
|
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
|
|
May 7
|
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 7
|
AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates
|
|
May 7
|
AbCellera Reports Q1 2024 Business Results
|
|
May 2
|
Insider Stock Buying Reaches US$1.61m On AbCellera Biologics
|
|
May 1
|
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
May 1
|
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
|
|
Apr 30
|
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 8
|
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
|
|
Apr 3
|
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
|